JP5224235B2 - カルシウム拮抗剤 - Google Patents
カルシウム拮抗剤 Download PDFInfo
- Publication number
- JP5224235B2 JP5224235B2 JP2007260673A JP2007260673A JP5224235B2 JP 5224235 B2 JP5224235 B2 JP 5224235B2 JP 2007260673 A JP2007260673 A JP 2007260673A JP 2007260673 A JP2007260673 A JP 2007260673A JP 5224235 B2 JP5224235 B2 JP 5224235B2
- Authority
- JP
- Japan
- Prior art keywords
- calcium
- calcium antagonist
- present
- active ingredient
- antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229940127291 Calcium channel antagonist Drugs 0.000 title claims description 57
- 239000000480 calcium channel blocker Substances 0.000 title claims description 46
- 239000003795 chemical substances by application Substances 0.000 claims description 14
- 239000004480 active ingredient Substances 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 12
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 7
- 239000011575 calcium Substances 0.000 claims description 7
- 229910052791 calcium Inorganic materials 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 7
- 230000005764 inhibitory process Effects 0.000 claims description 6
- 230000003834 intracellular effect Effects 0.000 claims description 6
- 208000001286 intracranial vasospasm Diseases 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- NEDIAPMWNCQWNW-UHFFFAOYSA-N massoia lactone Chemical compound CCCCCC1CC=CC(=O)O1 NEDIAPMWNCQWNW-UHFFFAOYSA-N 0.000 claims description 3
- DKHZWQLGZWVFFH-SECBINFHSA-N (2r)-2-hexyl-2h-furan-5-one Chemical group CCCCCC[C@H]1OC(=O)C=C1 DKHZWQLGZWVFFH-SECBINFHSA-N 0.000 claims description 2
- 102000013830 Calcium-Sensing Receptors Human genes 0.000 claims description 2
- 108010050543 Calcium-Sensing Receptors Proteins 0.000 claims description 2
- 241000186660 Lactobacillus Species 0.000 claims description 2
- 208000005392 Spasm Diseases 0.000 claims description 2
- 206010047139 Vasoconstriction Diseases 0.000 claims description 2
- 239000003416 antiarrhythmic agent Substances 0.000 claims description 2
- 239000003112 inhibitor Substances 0.000 claims description 2
- 229940039696 lactobacillus Drugs 0.000 claims description 2
- 210000003205 muscle Anatomy 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 230000025033 vasoconstriction Effects 0.000 claims description 2
- CJAONIOAQZUHPN-KKLWWLSJSA-N ethyl 12-[[2-[(2r,3r)-3-[2-[(12-ethoxy-12-oxododecyl)-methylamino]-2-oxoethoxy]butan-2-yl]oxyacetyl]-methylamino]dodecanoate Chemical compound CCOC(=O)CCCCCCCCCCCN(C)C(=O)CO[C@H](C)[C@@H](C)OCC(=O)N(C)CCCCCCCCCCCC(=O)OCC CJAONIOAQZUHPN-KKLWWLSJSA-N 0.000 description 13
- 238000002156 mixing Methods 0.000 description 12
- 239000003205 fragrance Substances 0.000 description 11
- 235000013305 food Nutrition 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 239000003710 calcium ionophore Substances 0.000 description 8
- 230000002776 aggregation Effects 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- -1 phenol compound Chemical class 0.000 description 7
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 238000004220 aggregation Methods 0.000 description 6
- 229910001424 calcium ion Inorganic materials 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 239000003995 emulsifying agent Substances 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000003381 stabilizer Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010050661 Platelet aggregation inhibition Diseases 0.000 description 3
- 244000299461 Theobroma cacao Species 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 229960004676 antithrombotic agent Drugs 0.000 description 3
- 206010003119 arrhythmia Diseases 0.000 description 3
- 230000006793 arrhythmia Effects 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 239000002270 dispersing agent Substances 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 101000783577 Dendroaspis angusticeps Thrombostatin Proteins 0.000 description 2
- 101000783578 Dendroaspis jamesoni kaimosae Dendroaspin Proteins 0.000 description 2
- 229940127218 antiplatelet drug Drugs 0.000 description 2
- 239000003788 bath preparation Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000002213 calciumantagonistic effect Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 235000014510 cooky Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000008157 edible vegetable oil Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000013861 fat-free Nutrition 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 1
- 0 *C(CC=C1)OC1=O Chemical compound *C(CC=C1)OC1=O 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- UYNVMODNBIQBMV-UHFFFAOYSA-N 4-[1-hydroxy-2-[4-(phenylmethyl)-1-piperidinyl]propyl]phenol Chemical compound C1CC(CC=2C=CC=CC=2)CCN1C(C)C(O)C1=CC=C(O)C=C1 UYNVMODNBIQBMV-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 206010059109 Cerebral vasoconstriction Diseases 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010023230 Joint stiffness Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 206010047163 Vasospasm Diseases 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 229940124532 absorption promoter Drugs 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 229940124575 antispasmodic agent Drugs 0.000 description 1
- 235000021425 apple cider vinegar Nutrition 0.000 description 1
- 229940088447 apple cider vinegar Drugs 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 230000009087 cell motility Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000020186 condensed milk Nutrition 0.000 description 1
- 229940124558 contraceptive agent Drugs 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000013611 frozen food Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 210000004623 platelet-rich plasma Anatomy 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000033904 relaxation of vascular smooth muscle Effects 0.000 description 1
- 239000008257 shaving cream Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000002883 vasorelaxation effect Effects 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
Description
本発明におけるカルシウム拮抗作用の試験としては、カルシウムイオノフォア(A23187)を惹起剤とする血小板凝集抑制試験を採用した。カルシウムイオノフォアは、細胞内にカルシウムイオンを流入させる物質であり、多血小板血漿(以下、PRPという。)に加えた場合は血小板の凝集を惹起する。すなわち、PRPに被検物質を加え、カルシウムイオノフォア(A23187)を添加したときに血小板の凝集が阻害されれば、その被検物質試料はカルシウム拮抗作用を有するといえる。
・PRP+A23187のみを加えたときの最大凝集率をAとする。
・被験物質+PRP+A23187を加えたときの最大凝集率をBとする。
・凝集阻害率(%)をCとすると
C=100−B/A×100。
前記試験方法において、被験物質の濃度が1mMから開始して、順次、阻害活性が消失するまで試料を1/2希釈して添加し、血小板凝集阻害活性を測定した。その試験結果を表1に示す。
・錠剤配合例(配合割合は質量比である。)
──────────────────────
本発明のカルシウム拮抗剤 5.0
6%HPC乳糖 80.0
ステアリン酸マグネシウム 4.0
バレイショデンプン 6.0
──────────────────────
・軟膏剤配合例(配合割合は質量比である。)
─────────────────────────
白色ワセリン 20.0
ステアリルアルコール 22.0
プロピレングリコール 12.0
ラウリル硫酸ナトリウム 1.5
パラベン 0.2
本発明のカルシウム拮抗剤 5.0
精製水 39.3
─────────────────────────
・入浴剤配合例(配合割合は質量比である。)
――――――――――――――――――――――─
炭酸水素ナトリウム 50.0
硫酸ナトリウム 45.0
本発明のカルシウム拮抗剤 1.3
香料 0.7
色素 3.0
───────────────────────
以下に、本発明のカルシウム拮抗剤のうち、血小板凝集抑制剤の食品への配合例について一例を示す。
・アイスクリーム配合例(配合割合は質量比である。)
────────────────────────
全脂練乳 10.0
生クリーム 9.4
無塩バター 2.0
脱脂粉乳 3.4
砂糖 12.0
安定剤 0.3
乳化剤 0.2
pH調整剤 0.1
カラメル色素 0.1
本発明のカルシウム拮抗剤 0.01
香料 0.01
水 49.0
────────────────────────
・クッキー生地配合例(配合割合は質量比である。)
────────────────────────
薄力粉 62.5
全粒粉 37.5
ショートニング 30.0
全卵 30.0
砂糖 20.0
水飴 1.0
脱脂粉乳 5.0
食塩 1.2
食用油脂 30.0
重炭酸ソーダ 1.0
重炭酸アンモニウム 1.0
本発明のカルシウム拮抗剤 0.1
香料 0.3
水 11.0
────────────────────────
・チョコレート配合例(配合割合は質量比である。)
─────────────────────────
カカオ液 12.0
カカオバター 24.0
ショ糖 33.0
フルクリームミルクパウダー 19.0
スキムミルクパウダー 11.4
レシチン 0.5
本発明のカルシウム拮抗剤 0.01
香料 0.1
─────────────────────────
・ノンオイルドレッシング配合例(配合割合は質量比である。)
─────────────────────────
濃口醤油 10.0
醸造酢 6.0
リンゴ酢 5.0
レモン果汁 4.0
液糖 7.0
食塩 2.0
調味料 7.0
香料 0.2
本発明のカルシウム拮抗剤 0.01
水 50.0
─────────────────────────
・飲料配合例(配合割合は質量比である。)
――――――――――――――――――――――───
果糖ぶどう糖液糖 60.0
アップル透明果汁 4.3
クエン酸 2.3
クエン酸三ナトリウム 0.8
アスコルビン酸 0.2
スクラロース 0.03
アセスルファムカリウム 0.02
香料 0.99
本発明のカルシウム拮抗剤 0.1
水 31.0
――――――――――――――――――――――───
・チューインガム配合例(配合割合は質量比である。)
――――――――――――――――――――――─
ガムベース 20.0
砂糖 60.0
ブドウ糖 10.0
水飴 8.0
グリセリン 5.0
香料 0.9
本発明のカルシウム拮抗剤 0.1
───────────────────────
Claims (7)
- 2−デセノ−δ−ラクトンを有効成分として含有する請求項1に記載のカルシウム拮抗剤。
- 2−デセノ−δ−ラクトンが(R)−2−デセノ−δ−ラクトンであることを特徴とする請求項2に記載のカルシウム拮抗剤。
- 請求項1乃至3のいずれかに記載のカルシウム拮抗剤を有効成分とする抗不整脈剤。
- 請求項1乃至3のいずれかに記載のカルシウム拮抗剤を有効成分とする血管収縮改善剤。
- 請求項1乃至3のいずれかに記載のカルシウム拮抗剤を有効成分とする抗脳血管攣縮剤または皮膚および筋肉に対する抗攣縮剤。
- 請求項1乃至3のいずれかに記載のカルシウム拮抗剤を有効成分として含有し、細胞内遊離カルシウム阻害および/または細胞内カルシウム受容体阻害および/または細胞内カルシウム関連蛋白質阻害のための医薬品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007260673A JP5224235B2 (ja) | 2007-10-04 | 2007-10-04 | カルシウム拮抗剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007260673A JP5224235B2 (ja) | 2007-10-04 | 2007-10-04 | カルシウム拮抗剤 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013006121A Division JP5626609B2 (ja) | 2013-01-17 | 2013-01-17 | カルシウム拮抗剤 |
JP2013006120A Division JP2013075914A (ja) | 2013-01-17 | 2013-01-17 | カルシウム拮抗剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009091262A JP2009091262A (ja) | 2009-04-30 |
JP5224235B2 true JP5224235B2 (ja) | 2013-07-03 |
Family
ID=40663599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007260673A Expired - Fee Related JP5224235B2 (ja) | 2007-10-04 | 2007-10-04 | カルシウム拮抗剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5224235B2 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5581120B2 (ja) * | 2010-06-07 | 2014-08-27 | 花王株式会社 | 電位依存性カチオンチャネル抑制剤 |
JP5469781B1 (ja) * | 2012-03-27 | 2014-04-16 | 辻本化学工業株式会社 | PPARsアゴニスト活性亢進薬 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63255222A (ja) * | 1987-04-14 | 1988-10-21 | Nippon Petrochem Co Ltd | クマリン類からなる虚血性心疾患治療用カルシウム拮坑剤 |
JPH09124476A (ja) * | 1995-11-06 | 1997-05-13 | Pola Chem Ind Inc | カルシウム拮抗剤 |
JP2001240528A (ja) * | 2000-02-29 | 2001-09-04 | Soda Aromatic Co Ltd | チロシナーゼ活性阻害剤 |
JP2004323476A (ja) * | 2003-04-28 | 2004-11-18 | Soda Aromatic Co Ltd | 抗真菌剤およびそれを用いた抗菌製品 |
JP2005035929A (ja) * | 2003-07-15 | 2005-02-10 | Soda Aromatic Co Ltd | 抗菌剤およびそれを用いた抗菌製品 |
-
2007
- 2007-10-04 JP JP2007260673A patent/JP5224235B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2009091262A (ja) | 2009-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4887499B2 (ja) | 野生種スイカ抽出物を含有する活性酸素消去剤ならびに保湿剤 | |
US8426386B2 (en) | NK1 receptor antagonist composition | |
JP2010053122A (ja) | 脂質合成阻害剤 | |
JP5224234B2 (ja) | 血小板凝集抑制剤 | |
JP5224235B2 (ja) | カルシウム拮抗剤 | |
US11306117B2 (en) | Whitening composition containing novel quercetin-based compound | |
JP5305419B2 (ja) | 血小板凝集抑制剤 | |
JP5626609B2 (ja) | カルシウム拮抗剤 | |
JP6456032B2 (ja) | Sirt1活性化剤および当該Sirt1活性化剤の利用 | |
JP4657778B2 (ja) | アラキドン酸代謝抑制剤 | |
JP5536913B2 (ja) | 血小板凝集抑制剤 | |
JP7030692B2 (ja) | 3-o-ガロイル-3,3’,5,5’,7-ペンタヒドロキシフラボンを含む保湿用組成物 | |
JP7179025B2 (ja) | 後発酵茶由来の新規なケンペロール系化合物を含む抗炎症組成物 | |
JP4953627B2 (ja) | アラキドン酸代謝抑制剤 | |
JP2013075914A (ja) | カルシウム拮抗剤 | |
JP5527736B2 (ja) | 血小板凝集抑制剤 | |
JP2008013486A (ja) | アラキドン酸代謝抑制剤 | |
JP2013082738A (ja) | 血小板凝集抑制剤 | |
JP5536912B2 (ja) | 血小板凝集抑制剤 | |
CA3109614C (en) | Composition containing moringa extract and/or pulverized product | |
JP5507892B2 (ja) | 活性酸素起因障害抑制剤 | |
JP7071406B2 (ja) | 新規なクエルセチン系化合物を含む抗炎症組成物 | |
JP6753662B2 (ja) | 抗糖化剤 | |
JP2013082739A (ja) | 血小板凝集抑制剤 | |
JP2024041535A (ja) | Sirt1活性化剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20100226 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20100226 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100819 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121120 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20121225 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20121225 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130117 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130226 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130304 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5224235 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160322 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |